[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU1403501A - Novel composition and use - Google Patents

Novel composition and use

Info

Publication number
AU1403501A
AU1403501A AU14035/01A AU1403501A AU1403501A AU 1403501 A AU1403501 A AU 1403501A AU 14035/01 A AU14035/01 A AU 14035/01A AU 1403501 A AU1403501 A AU 1403501A AU 1403501 A AU1403501 A AU 1403501A
Authority
AU
Australia
Prior art keywords
novel composition
novel
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14035/01A
Other languages
English (en)
Inventor
Karen Lewis
Nicola Jayne Lillott
Donald Colin Mackenzie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9927121.5A external-priority patent/GB9927121D0/en
Priority claimed from GB0013238A external-priority patent/GB0013238D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU1403501A publication Critical patent/AU1403501A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU14035/01A 1999-11-16 2000-11-16 Novel composition and use Abandoned AU1403501A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9927121.5A GB9927121D0 (en) 1999-11-16 1999-11-16 Novel composition and use
GB9927121 1999-11-16
GB0013238 2000-05-31
GB0013238A GB0013238D0 (en) 2000-05-31 2000-05-31 Novel composition and use
PCT/GB2000/004363 WO2001035940A2 (en) 1999-11-16 2000-11-16 Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride

Publications (1)

Publication Number Publication Date
AU1403501A true AU1403501A (en) 2001-05-30

Family

ID=26244395

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14035/01A Abandoned AU1403501A (en) 1999-11-16 2000-11-16 Novel composition and use

Country Status (4)

Country Link
EP (1) EP1231917A2 (ja)
JP (1) JP2003514011A (ja)
AU (1) AU1403501A (ja)
WO (1) WO2001035940A2 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125516A (en) 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
EP1278513B1 (en) * 2000-05-01 2007-07-18 Aeropharm Technology, LLC A core formulation
AU2001273310B2 (en) * 2001-07-10 2004-10-07 Kos Life Sciences, Inc. A core formulation
AU2001273290B2 (en) * 2001-07-10 2004-10-07 Kos Life Sciences, Inc. Core formulation comprising troglitazone and a biguanide
EP1515701B1 (en) 2002-06-17 2014-09-17 Inventia Healthcare Private Limited Process for the manufacture of multilayer tablet compositions comprising thiazolidinedione and biguanide
US20060286168A1 (en) * 2002-07-11 2006-12-21 Masahiko Koike Process for producing coated preparation
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
EP1539144B1 (en) * 2002-09-20 2014-12-24 Andrx Labs Llc Multistage formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
UA80991C2 (en) 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
ZA200506397B (en) * 2003-01-29 2006-11-29 Takeda Pharmaceutical Process for producing coated preparation
KR101114808B1 (ko) * 2003-01-29 2012-02-15 다케다 야쿠힌 고교 가부시키가이샤 피복 제제의 제조법
JP4567340B2 (ja) * 2003-01-29 2010-10-20 武田薬品工業株式会社 被覆製剤の製造方法
GB0318824D0 (en) * 2003-08-11 2003-09-10 Glaxo Group Ltd Novel composition
JP4739189B2 (ja) * 2004-04-14 2011-08-03 武田薬品工業株式会社 固形製剤
WO2010136847A1 (en) * 2009-05-26 2010-12-02 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Coated metformin with pioglitazone solution

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000054I1 (de) * 1997-06-18 2007-12-13 Smithkline Beecham Plc Behandlung der Diabetes mit Thiazolidindione und metformin
GB9715295D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
WO1999047128A1 (en) * 1998-03-19 1999-09-23 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method

Also Published As

Publication number Publication date
JP2003514011A (ja) 2003-04-15
EP1231917A2 (en) 2002-08-21
WO2001035940A2 (en) 2001-05-25
WO2001035940A3 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
IL190220A0 (en) Novel composition and use
AUPQ419099A0 (en) Novel compositions and methods
AU3731600A (en) Composition and structures made therefrom
AU4318000A (en) Agarobiose-containing composition
AU5634300A (en) Composition and films thereof
AU1890599A (en) Novel microorganism and use thereof
AU4431000A (en) Novel use
AU5567700A (en) Hair composition
AU1403501A (en) Novel composition and use
AU1290501A (en) Composition
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
AU2841801A (en) Triazolotriazinones and the use thereof
AU1152601A (en) Compositions and their use
EG22491A (en) Rest-breaking composition and use thereof
AU2176001A (en) Cosmetic composition
AU4779400A (en) Hair-treatment composition
AU7026100A (en) Dye compositions and uses
AU6310600A (en) Composition
GB9927927D0 (en) Compound composition and use
AU2399601A (en) Novel tachykinin-like polypeptides and use thereof
AU2669201A (en) Taccalonolides and their use
AU5979300A (en) Angiopoietin-6 and uses thereof
AU5567600A (en) Hairdye composition
AU5974100A (en) 6-carboxyphenyldihydropyridazinone derivatives and use thereof
AU5931300A (en) Ringene compositions and methods for use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase